We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current TERN market cap is 381.44M. The company's latest EPS is USD -1.3953 and P/E is -4.23.
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -16.83M | -24.16M | -21.16M | -33.18M | -24.06M |
| Net Income | -15.82M | -21.53M | -17.9M | -29.77M | -21.02M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 1M | 0 | 0 |
| Operating Income | -70.2M | -37.03M | -49.86M | -62.03M | -102.56M |
| Net Income | -68.61M | -29.35M | -50.16M | -60.35M | -90.21M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 287.03M | 301.29M | 289.7M | 271.69M | 268.52M |
| Total Liabilities | 10.08M | 13.6M | 15.55M | 13.26M | 13.15M |
| Total Equity | 276.94M | 287.68M | 274.15M | 258.43M | 255.37M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 23.9M | 92.29M | 168.07M | 287.03M | 268.52M |
| Total Liabilities | 19.7M | 23.7M | 7.77M | 10.08M | 13.15M |
| Total Equity | -90.76M | -117.44M | 160.3M | 276.94M | 255.37M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -49.11M | -14.38M | -27.38M | -48.07M | -67.39M |
| Investing | -22.27M | 27.93M | -62.91M | -85.22M | -37.99M |
| Financing | 167.1M | 27.58M | 28.07M | 28.09M | 41.95M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -66.22M | -29.81M | -41.83M | -49.11M | -67.39M |
| Investing | -3.86M | 6.69M | -119.7M | -22.27M | -37.99M |
| Financing | 62k | 85.52M | 134.39M | 167.1M | 41.95M |
| Market Cap | 381.44M |
| Price to Earnings Ratio | -4.23 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 4.77 |
| Price to Book Ratio | 1.49 |
| Dividend Yield | - |
| Shares Outstanding | 64.65M |
| Average Volume (1 week) | 813.96k |
| Average Volume (1 Month) | 770.62k |
| 52 Week Change | -44.96% |
| 52 Week High | 13.03 |
| 52 Week Low | 3.26 |
| Spread (Intraday) | 0.62 (9.83%) |
| Company Name | Terns Pharmaceuticals Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.ternspharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
